Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. The company is headquartered in West Lafayette, Indiana.
| Revenue (TTM) | $514.03M |
| Gross Profit (TTM) | $120.75M |
| EBITDA | $17.68M |
| Operating Margin | -13.40% |
| Return on Equity | -49.80% |
| Return on Assets | -3.14% |
| Revenue/Share (TTM) | $15.01 |
| Book Value | $3.17 |
| Price-to-Book | 0.10 |
| Price-to-Sales (TTM) | 0.02 |
| EV/Revenue | 0.922 |
| EV/EBITDA | 19.93 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.80% |
| Shares Outstanding | $34.40M |
| Float | $31.82M |
| % Insiders | 9.15% |
| % Institutions | 22.16% |
Volatility is currently contracting